BioSpace News Archive

Today Planned Parenthood affiliates in New York State are thrilled to announce the launch of Planned Parenthood Direct, a mobile app that allows New Yorkers to receive birth control pills and UTI treatment through their phones.

CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance business, part of CIT’s Commercial Finance division, served as sole lead arranger of $21.4 million in senior secured credit facilities for Virtus Real Estate Capital, a private equity real estate firm that focuses on cycle-resilient alternative property types.

The physician and healthcare policy consultant to share expertise on transparency and performance improvement measures with benchmarking solutions leader

Josef von Rickenbach will step down as Chairman of the Board of Directors effective December 31, 2018.

Leading IoT Security Company Provides Real-time Assessment of Risk Across University of Iowa Health Care’s Network of IoT Devices With Alerts and Guidance for Threat Response

Virence Health Technologies today announced it has achieved full accreditation for Centricity™ EDI Services from the Healthcare Network Accreditation Program (HNAP) of the Electronic Healthcare Network Accreditation Commission (EHNAC). EHNAC’s HNAP accreditation recognizes excellence in health data processing and transactions and ensures compliance with industry-established standards and HIPAA regulations.

The purchase price of US$18 Million is comprised of approximately US$6 Million paid upon closing of the transaction and a performance based earn-out of up to US$12 Million, to be paid in a combination of cash and stock.

Celgene licenses two TriNKET™ immunotherapy drug candidates built by Dragonfly for $24m plus milestones and royalties

Cerveau Technologies Inc. today announced that the Memory Aging and Cognition Centre (MACC) at the National University Health System (NUHS) in Singapore has initiated a study with an early stage imaging agent [18F]MK-6240 to be used in Positron Emission Tomography (PET) scans for assessing the level and progression of neurofibrillary tangles (NFTs) in the brain.

Main ingredient markedly reduces brain plaque load and improves short-term memory in pre-clinical testing